Paul Mahon
Vermogen: 24 M $ op 30-06-2026
Vermogen: 24 M $ op 30-06-2026
Paul A. Mahon is Co-Managing Director at Unither Therapeutik GmbH.
Mr. Mahon is Secretary, Executive VP & General Counsel at United Therapeutics Corp.
since 2003.
Mr. Mahon is Secretary, Executive VP & General Counsel at Miromatrix Medical, Inc. since 2023.
Mr. Mahon is partner at Hyperion Equity Partners Ltd. Mr. Mahon was Director at SteadyMed Ltd.
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 16-07-2026 | 45.172 ( 0,11% ) | 24 M $ | 30-06-2026 |
| Bedrijven | Functie | Begin |
|---|---|---|
| UNITED THERAPEUTICS CORPORATION | Algemeen Adviseur | 26-06-1996 |
| MIROMATRIX MEDICAL INC. | Algemeen Adviseur | 11-12-2023 |
Unither Therapeutik GmbH
Unither Therapeutik GmbH Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Algemeen Directeur | - |
| Bedrijven | Functie | Einde |
|---|---|---|
| STEADYMED LTD | Directeur/Bestuurslid | - |
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
| Bedrijven in privébezit | 4 |
|---|---|
United Therapeutics Corp.
United Therapeutics Corp. BiotechnologyHealth Technology Operates as a biotechnology company that develops and commercializes products to address the unmet medical needs of patients with chronic & life-threatening conditions | Health Technology |
Miromatrix Medical, Inc.
Miromatrix Medical, Inc. BiotechnologyHealth Technology Engages in research and development of fully biologic organs | Health Technology |
Unither Therapeutik GmbH
Unither Therapeutik GmbH Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
SteadyMed Ltd.
SteadyMed Ltd. Pharmaceuticals: MajorHealth Technology Engages in the research, development, and manufacture of pharmaceutical products | Health Technology |
Kies jouw editie
Alle financiële informatie op nationaal niveau